<DOC>
	<DOCNO>NCT01665534</DOCNO>
	<brief_summary>Salt main environmental risk factor involve atherosclerotic complication high risk variety cardiovascular ( CV ) diseases include hypertension , leave ventricular hypertrophy ( LVH ) , chronic kidney disease ( CKD ) heart failure . The link sodium cardiovascular disease complex involve blood pressure ( BP ) dependent independent mechanism . Among latter , inflammation suspect major effector arterial damage bring salt excess animal model . In human , C-Reactive Protein ( CRP ) associate directly dietary salt intake population-based survey link confirm study . This apparent discrepancy may depend observational ( i.e. , open confound ) nature study . Inflammatory cytokines essential short term systemic response environmental stressor . For example well establish TNF-α , cytokine modulates renin gene expression signal via TNF-receptor 2 , exerts protective effect myocardium stressful condition like experimental cardiac ischemia low level adiponectin detrimental effect set . Thus , inflammation-sodium relationship may non-linear severe salt restriction may actually trigger inflammation , hypothesis suggest observation biomarkers inflammation rise response salt depletion sequential study essential hypertensive . However , lack randomization study leave open question whether observed pro-inflammatory effect due change salt intake , unmeasured time-dependent effect ( ) . With background mind investigator setup randomize , single mask , cross-over study assess effect short term low salt diet biomarkers innate immunity patient uncomplicated essential hypertension .</brief_summary>
	<brief_title>Inflammatory Response Salt Essential Hypertension</brief_title>
	<detailed_description>The protocol conformity ethical guideline institution inform consent obtain participant . During run-in phase study , last 1 month , patient underwent standard arterial pressure measurement two separate occasion ( least 10 day apart ) consider eligible study casual arterial pressure exceed 140/90 mmHg . Patients randomize either 10-20 mmol sodium diet plus sodium tablet ( 180 mEq/die ) achieve 200 mmol intake /day , diet plus identical placebo tablet , two week . At end two-week period , patient underwent 24-hours urine collection , fast blood sample 24h ambulatory blood pressure monitoring ( see ) . Ambulatory monitoring perform device conform AAMI criterion ( Takeda 2420 model 7 , Takeda Medical , Osaka , Japan ) . Between 08.30 11.30 hour , placement device leave ( non-dominant ) arm , patient rest quietly armchair 15 min arterial pressure take automatically three time ( 5 min interval ) . Patients go home remain indoors throughout record day . They instruct spend relaxed , quiet day avoid physical effort . Recordings set 15 min interval 07.00 22.00 hour every 30 min sleeping hour ( 22.00 pm 07.00 ) . The calibration ambulatory recorder perform mercury sphygmomanometer record . Patients classify salt-sensitive change mean arterial pressure low high salt diet &gt; 10 % . Blood sample perform last day period 45 minute supine rest . The patient specifically instructed alter smoke habit , alcohol coffee intake modify level physical activity throughout study . Urinary sodium measure ion-selective electrode use Beckman ( Fullertone , CA , USA ) EA-2 Electrolyte Analyser . Serum urine creatinine measure colorimetric method use COBAS-Mira spectrophotometer ( Roche , Basel , Switzerland ) . The measurement plasma renin activity ( PRA ) plasma aldosterone concentration perform radioimmunoassay ( RIA ) use commercially available kit ( Technogenetics-Milan , Italy ) . Biomarkers inflammation endothelial integrity/function High sensitivity C-Reactive Protein ( hs-CRP ) measure plasma nephelometric method ( Dade-Behring , Scoppito , L'Aquila , Italy ) ( intra-assay CV : 3.5 % ; inter-assay CV : 3.4 % ; normal range &lt; 2.87 mg/L ) . Interleukin-6 ( intra-assay CV : 2.6 % ; inter-assay CV : 4.5 % , normal range &lt; 12.5 pg/mL ) TNF-α ( intra-assay CV : 4.7 % ; inter-assay CV : 5.8 % , normal range &lt; 15.6 pg/mL ) measure commercially available RIA kit ( R &amp; D System , Minneapolis , USA ) . High sensitivity procalcitonin ( PCT ) ( intra-assay CV : 2-3 % normal value &lt; 0.05 ng/mL ) measure immunofluorescence method ( Kriptor , BRAHMS , Henningsdorf , Germany ) . Plasma Adiponectin ( intra-assay CV : 3.9 % ; inter-assay CV : 8.4 % ) Leptin ( intra-assay CV : 5.0 % ; inter-assay CV : 4.5 % ) measure RIA kit ( Linco Research Missouri , USA ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Patients uncomplicated , untreated essential hypertension ( age &gt; 18 year ) . Patients secondary hypertension , liver disease , neoplasia chronic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>inflammation</keyword>
	<keyword>salt intake</keyword>
</DOC>